• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

January 20, 2025

Air Pollution and Seasonal Variability Associated With Asthma- and COPD-Related Hospital Admissions

Author(s):

Gillian McGovern, Associate Editor

Key Takeaways

  • Air pollution, particularly PM10, significantly influences asthma and COPD hospital admissions, with a higher impact than PM2.5.
  • Meteorological factors, including air temperature and humidity, play a crucial role in exacerbating respiratory conditions.
  • Hospital admissions for asthma and COPD are more frequent in winter, correlating with higher pollution levels.
  • Future research should explore seasonal variations and non-linear relationships to enhance understanding of climate impacts on respiratory health.
SHOW MORE

The authors found that humidity, cold and heat waves, and air pollution led to a higher likelihood of asthma- and chronic obstructive pulmonary disease (COPD)-related hospitalizations.

Hospitalization for asthma and COPD -- Image credit: Spiroview Inc. | stock.adobe.com

Image credit: Spiroview Inc. | stock.adobe.com

Because climate change and air pollution are pressing public health concerns, it is crucial to closely monitor their impact on respiratory diseases, such as obstructive lung diseases. Authors of a study published Scientific Reports investigated the relationships between meteorological parameters, levels of PM2.5 and PM10, and the frequency of hospital admissions for chronic obstructive pulmonary disorder (COPD) and asthma.

The data analyzed for this study were obtained from medical records of patients who were hospitalized from January 1, 2012, through December 31, 2021, in the Warmia and Mazury Centre for Pulmonary Diseases in Olsztyn, Poland. The authors examined information on the hospitalization of patients diagnosed with J44 (COPD) and J45 (asthma) according to the ICD-10 classification.

Additionally, planned admissions related to desensitization, rehabilitation, and treatment according to the protocol of the drug program were extracted from the collected data. Therefore, only hospitalizations related to the onset of asthma or COPD symptoms were singled out, eliminating planned admissions not directly related to exacerbations of these conditions. For this study, adult patients aged 18 years and older with either asthma or COPD were included in the analysis.

Further, meteorological data were obtained from the Institute of Meteorology and Water Management of the National Research Institute. This data includes values of daily mean, maximum and minimum air temperature, wind speed, relative humidity, precipitation, as well as levels of PM2.5 and PM10. Additionally, the humidity index (Humididex)—which used oC—accounted for human-felt temperature, which was determined using ambient thermal and humidity conditions.

A total of 1419 records of patients with asthma (females: n = 869; males: n = 550) and 862 patients with COPD (females: n = 457; males: n = 405), with respective average ages of 59.51 (females) and 58.39 (males) years, and 69.38 (females) and 69.68 (males) years. The average length of hospital stay was about 4.25 (females) and 5.23 days (males) in the asthma group, and about 13.96 (females) and 12.92 days (males) in the COPD group. Both asthma and COPD patients were most often hospitalized during winter months. For both groups, the most frequent comorbidities were thyroid disorders (asthma: n = 290; COPD: n = 150), arterial hypertension (asthma: n = 653; COPD: n = 467), and cardiac insufficiency (asthma: n = 75; COPD: n = 137).

The investigators determined that the number of hospitalization admissions of patients with asthma and COPD exacerbations was largely dependent on the atmospheric conditions as well as air pollution levels. This was represented by the levels of both PM2.5 and PM10. The authors observed that the contribution of air pollution to the incidence of asthma and COPD is highest for overall air pollution (85.9%), with PM10 (45.6%) having more influence than PM2.5 (40.3%). In addition, for meteorological factors (81%), the most influential were air temperature (33.2%), relative humidity (10.1%), and precipitation (16.4%).

Additionally, high levels of PM2.5 and PM10 were strongly associated with more frequent asthma- and COPD-related hospital admissions. The average concentration of PM2.5 during the study period was about 16.1 µg/m3, and the average monthly concentrations exceeded daily and annual norms in winter months. The authors also observed that the correlation between PM2.5 and PM10 with the number of hospital admissions demonstrates evident differences in the winter half-year (PM2.5: 0.212 and PM10: 0.352) and the summer half-year (no significant relationship).

During the study period, out of all hospitalized patients with asthma (n = 1419; 17%) and COPD (n = 862; 18%), were admitted during the summer when Tmax was greater than 22 °C. The highest patient numbers, which was approximately 30%, were recorded when thermal-humidity discomfort was minimal or unnoticeable (Humidex: < 29). However, a considerable proportion of ‘summer’ patients—approximately 32% for asthma and 29% for COPD—presented during periods of slight to moderate discomfort, with Humidex values in class 2 through 4 (30–45). Notably, during periods of strong discomfort (Humidex class 4: 40–45), only 4 patients were admitted to hospital. The average number of admissions in July and August were statistically greater than in the remaining months of the warm period.

The investigators suggested that future studies should integrate analyses by season while exploring non-linear relationships. Additionally, the authors acknowledged that their results must be referred to the parameter that was not examined (eg, seasonal variability of upper respiratory tract infection).

REFERENCE
Romaszko-Wojtowicz A, Dragańska E, Doboszyńska A, Glińska-Lewczuk K. Impact of seasonal biometeorological conditions and particulate matter on asthma and COPD hospital admissions. Sci Rep. 2025;15(450) doi:10.1038/s41598-024-84739-9
Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
Plaque buildup in artery | Image Credit: © SK imagine - stock.adobe.com
May 8th 2025

Obicetrapib Plus Ezetimibe Reduced LDL-C in Patients With or at Risk of Atherosclerotic Cardiovascular Disease

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
U.S. House of Representatives, Washington, DC USA
May 8th 2025

Coalition of Pharmacy Organizations Urges Congress to Pass ECAPS Legislation

Luke Halpern, Assistant Editor
Pharmacy Times pharmacy focus oncology edition
May 5th 2025

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Alexandra Gerlach, Associate Editor
Dumbbell with pink breast cancer ribbon | Image Credit: © fidaolga - stock.adobe.com
May 8th 2025

The Role of Physical Activity in Breast Cancer Risk Reduction and Survival

Angela Chau, PharmD
3D rendering of antibody drug conjugates | Image Credit: © Love Employee - stock.adobe.com
May 8th 2025

Neoadjuvant Trastuzumab Deruxtecan Improves Pathologic Complete Response in Patients With HER2+ Early Breast Cancer

Alexandra Gerlach, Associate Editor
Related Content
Advertisement
Plaque buildup in artery | Image Credit: © SK imagine - stock.adobe.com
May 8th 2025

Obicetrapib Plus Ezetimibe Reduced LDL-C in Patients With or at Risk of Atherosclerotic Cardiovascular Disease

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
U.S. House of Representatives, Washington, DC USA
May 8th 2025

Coalition of Pharmacy Organizations Urges Congress to Pass ECAPS Legislation

Luke Halpern, Assistant Editor
Pharmacy Times pharmacy focus oncology edition
May 5th 2025

Novel HER2-low Therapies and Pharmacist-Led ADC Sequencing

Alexandra Gerlach, Associate Editor
Dumbbell with pink breast cancer ribbon | Image Credit: © fidaolga - stock.adobe.com
May 8th 2025

The Role of Physical Activity in Breast Cancer Risk Reduction and Survival

Angela Chau, PharmD
3D rendering of antibody drug conjugates | Image Credit: © Love Employee - stock.adobe.com
May 8th 2025

Neoadjuvant Trastuzumab Deruxtecan Improves Pathologic Complete Response in Patients With HER2+ Early Breast Cancer

Alexandra Gerlach, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.